Literature DB >> 12516777

Human immunodeficiency virus type 1 subtype C exhibits higher transactivation activity of Tat than subtypes B and E.

Takeshi Kurosu1, Tetsu Mukai, Satoshi Komoto, Madiha S Ibrahim, Yong-Gang Li, Takeshi Kobayashi, Shoutaro Tsuji, Kazuyoshi Ikuta.   

Abstract

Although human immunodeficiency virus type 1 (HIV-1) subtypes C and E are expanding faster and seem to be of greater global significance than HIV-1 subtype B, there is only little information about Tat activity of such non-B subtypes. Here, we showed evidence that subtype C Tat exhibits higher transcriptional activity from the HIV-1 long-terminal repeat (LTR) in a human T-cell line, compared with subtypes B and E. This higher activity of subtype C Tat was not due to the LTR, but to the Tat sequence variability. We examined three candidate regions with sequence for the higher activity of subtype C Tat, such as the cysteine-rich motif, the basic domain, and the 2nd exon. The results showed that the variation in subtype C Tat at two amino acid residues, Ser57 and Glu63 in stead of Arg57 and Gln63 in subtypes B and E, within and close to the basic domain were involved in the higher activity of subtype C Tat. This variation did not affect its nuclear localization activity. Thus, there may be a significant advantage for the high Tat activity on subtype C replication.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12516777     DOI: 10.1111/j.1348-0421.2002.tb02766.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  19 in total

1.  Mutual information analysis reveals coevolving residues in Tat that compensate for two distinct functions in HIV-1 gene expression.

Authors:  Siddharth S Dey; Yuhua Xue; Marcin P Joachimiak; Gregory D Friedland; John C Burnett; Qiang Zhou; Adam P Arkin; David V Schaffer
Journal:  J Biol Chem       Date:  2012-01-17       Impact factor: 5.157

Review 2.  Genetic variation and function of the HIV-1 Tat protein.

Authors:  Cassandra Spector; Anthony R Mele; Brian Wigdahl; Michael R Nonnemacher
Journal:  Med Microbiol Immunol       Date:  2019-03-05       Impact factor: 3.402

Review 3.  Genetic variation and HIV-associated neurologic disease.

Authors:  Satinder Dahiya; Bryan P Irish; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

4.  Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.

Authors:  Yan Desfosses; Mayra Solis; Qiang Sun; Nathalie Grandvaux; Carine Van Lint; Arsene Burny; Anne Gatignol; Mark A Wainberg; Rongtuan Lin; John Hiscott
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Functional Incompatibility between the Generic NF-κB Motif and a Subtype-Specific Sp1III Element Drives the Formation of the HIV-1 Subtype C Viral Promoter.

Authors:  Anjali Verma; Pavithra Rajagopalan; Rishikesh Lotke; Rebu Varghese; Deepak Selvam; Tapas K Kundu; Udaykumar Ranga
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

6.  Amino acid sequence divergence of Tat protein (exon1)of subtype B and C HIV-1 strains: Does it have implications for vaccine development?

Authors:  Abraham Joseph Kandathil; Rajesh Kannangai; Oriapadickal Cherian Abraham; Susanne Alexander Pulimood; Gopalan Sridharan
Journal:  Bioinformation       Date:  2009-12-12

7.  Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India.

Authors:  Jayashree Das Gupta; P Satishchandra; Kumarpillai Gopukumar; Frances Wilkie; Drenna Waldrop-Valverde; Ronald Ellis; Raymond Ownby; D K Subbakrishna; Anita Desai; Anupa Kamat; V Ravi; B S Rao; K S Satish; Mahendra Kumar
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

8.  HIV-1C and HIV-1B Tat protein polymorphism in Southern Brazil.

Authors:  Sérgio Monteiro de Almeida; Indianara Rotta; Luine Rosele Renaud Vidal; Jucelia Stadinicki Dos Santos; Avindra Nath; Kory Johnson; Scott Letendre; Ronald J Ellis
Journal:  J Neurovirol       Date:  2021-01-18       Impact factor: 2.643

9.  Impact of Tat Genetic Variation on HIV-1 Disease.

Authors:  Luna Li; Satinder Dahiya; Sandhya Kortagere; Benjamas Aiamkitsumrit; David Cunningham; Vanessa Pirrone; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virol       Date:  2012-07-30

Review 10.  Addressing an HIV cure in LMIC.

Authors:  Sherazaan D Ismail; Joshua Pankrac; Emmanuel Ndashimye; Jessica L Prodger; Melissa-Rose Abrahams; Jamie F S Mann; Andrew D Redd; Eric J Arts
Journal:  Retrovirology       Date:  2021-08-03       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.